Senesco Technologies Inc Sample Contracts

AGREEMENT ---------
Registration Rights Agreement • February 14th, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • December 6th, 2013 • Senesco Technologies Inc • Services-commercial physical & biological research • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of December ____, 2013, between Senesco Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • March 29th, 2010 • Senesco Technologies Inc • Services-commercial physical & biological research

This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 26, 2010, between Senesco Technologies Inc., a Delaware corporation (the “Company”), and each of the purchasers who are signatories hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

WARRANT -------
Senesco Technologies Inc • January 2nd, 2002 • Services-commercial physical & biological research • Delaware
AGREEMENT ---------
Registration Rights Agreement • September 28th, 2000 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
Warrant No. [ ] Number of Shares: [ ] (subject to adjustment)
Senesco Technologies Inc • May 9th, 2002 • Services-commercial physical & biological research • New Jersey
AGREEMENT ---------
Registration Rights Agreement • January 2nd, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
SECTION I
Common Stock Purchase Agreement • September 28th, 2000 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
SECTION I
Securities Purchase Agreement • February 14th, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
SECTION I
Securities Purchase Agreement • February 14th, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
COMMON STOCK PURCHASE WARRANT Senesco Technologies, Inc.
Senesco Technologies Inc • December 12th, 2013 • Services-commercial physical & biological research

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after December ___, 2013 (the “Initial Exercise Date”) and on or prior to the close of business on the sixth month anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Senesco Technologies, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • December 12th, 2013 • Senesco Technologies Inc • Services-commercial physical & biological research • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of December ____, 2013, between Senesco Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

ELOXX PHARMACEUTICALS, INC. AND [•], AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [•], 20[•] ELOXX PHARMACEUTICALS, INC. FORM OF COMMON STOCK WARRANT AGREEMENT
Warrant Agreement • November 16th, 2018 • Eloxx Pharmaceuticals, Inc. • Services-commercial physical & biological research • New York

THIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between ELOXX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).

AGREEMENT ---------
Registration Rights Agreement • September 28th, 2000 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 29th, 2010 • Senesco Technologies Inc • Services-commercial physical & biological research • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of March 26, 2010, between Senesco Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

SECTION I
Securities Purchase Agreement • January 2nd, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
ELOXX PHARMACEUTICALS, INC. Shares of Common Stock ($0.01 par value per share) SALES AGREEMENT
Sales Agreement • September 30th, 2021 • Eloxx Pharmaceuticals, Inc. • Services-commercial physical & biological research • New York

Eloxx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC (the “Agent”), as follows:

WARRANT -------
Senesco Technologies Inc • January 2nd, 2002 • Services-commercial physical & biological research • Delaware
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • October 1st, 2013 • Senesco Technologies Inc • Services-commercial physical & biological research • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of September 30, 2013, between Senesco Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

ELOXX PHARMACEUTICALS, INC. and [•], AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [•], 20[•] ELOXX PHARMACEUTICALS, INC. FORM OF DEBT SECURITIES WARRANT AGREEMENT
Warrant Agreement • November 16th, 2018 • Eloxx Pharmaceuticals, Inc. • Services-commercial physical & biological research • New York

This DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between ELOXX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

RECITALS
Development and License Agreement • May 17th, 2004 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
PLACEMENT AGENT AGREEMENT
Placement Agent Agreement • September 28th, 2000 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
BETWEEN
Lease Agreement • May 15th, 2001 • Senesco Technologies Inc • Services-commercial physical & biological research